Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03008408
Title Phase II Ribociclib, Everolimus and Letrozole in Endometrial Cancer
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors M.D. Anderson Cancer Center
Indications

endometrial carcinoma

Therapies

Everolimus + Letrozole + Ribociclib

Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
Lyndon Baines Johnson General Hospital Recruiting Houston Texas 77026-1967 United States Details
M D Anderson Cancer Center Recruiting Houston Texas 77030 United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field